|
Ixazomib Clinical Trials
3 actively recruiting trials across 2 locations
▼ -1 trial since June 2026
Also known as: Ninlaro, Ninlaro®
Pipeline
Phase 4: 1Phase 1/2: 2
Top Sponsors
- Second Affiliated Hospital, School of Medicine, Zhejiang University1
- Karyopharm Therapeutics Inc1
- CellCentric Ltd.1
Indications
- Multiple Myeloma3
- Cancer3
- Higher-risk Myelodysplastic Syndrome1
- Peripheral T Cell Lymphoma1
- Haematological Malignancy1
Other1 trial
Gilbert, Arizona1 trial
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Banner MD Anderson Cancer Center
Phase 1/2
Atlanta, Georgia1 trial
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Emory Winship Cancer Institute
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.